Ledger.Open graph →

SEC Form D · filed November 21, 2018

Inozyme Pharma, Inc

Offering

$10.7M

Sold

$10.7M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

Boston, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

William Bennett · Chicago, ILExec · Director Martin Edwards · Boston, MADirector Rob Hopfner · Boston, MADirector Matthew Goebel · Chicago, ILDirector Harley Miller · Brooklyn, NYDirector Andrew Denardo · Red Bank, NJDirector Robert D. Ghiselli · Glendale, CODirector Sean Lavies · Indianapolis, INExec · Director Axel Bolte · Boston, MAExec · Director Reinaldo Diaz · Boston, MADirector Michael J. Hughes · Evanston, ILDirector Edward Mathers · Boston, MADirector Eric Huebner · Indianapolis, INDirector Robert Saunders · Chicago, ILDirector GGV Discovery II L.L.C · Menlo Park, CADirector Daniel J. Hopkins · Evanston, ILDirector Sean Mullins · Indianapolis, INDirector Joseph Schlessinger · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗